Bifidobacterium breve CCFM683 could ameliorate DSS-induced colitis in mice primarily via conjugated linoleic acid production and gut microbiota modulation

Bo Yang, Haiqin Chen, He Gao, Juntong Wang, Catherine Stanton, R Paul Ross, Hao Zhang, Wei Chen
2018-10-01
Abstract:Probiotics have been proposed as the alternative therapy for IBD, but with strong strain-dependent effects. The current work aims to investigate the protective effect of B. breve CCFM683 on a DSS-induced colitis. CCFM683 significantly inhibited disease activity index, colon shortening and myeloperoxidase activity. Additionally, CCFM683 improved the histological damage, protected the colonic mucous layer integrity and significantly attenuated the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), while up-regulated the expression of colonic anti-inflammatory cytokine IL-10 and nuclear receptor PPARγ. Meanwhile, the concentration of colonic conjugated linoleic acid (CLA) was significantly increased in response to CCFM683 supplementation, which demonstrates that CCFM683 prevents colitis in correlation with local CLA production. Furthermore, CCFM683 could rebalance the gut microbial …
What problem does this paper attempt to address?